Simplify Logo

Full-Time

Specialty Account Manager

Auvelity, Flint, MI

Posted on 6/27/2024

Axsome Therapeutics Inc

Axsome Therapeutics Inc

501-1,000 employees

Develops therapies for CNS disorders

Hardware
Biotechnology

Compensation Overview

$110k - $150kAnnually

+ Bonus + Equity

Senior

Flint, MI, USA

Category
Strategic Account Management
Sales & Account Management
Required Skills
Sales
Communications
Marketing
Requirements
  • Bachelor’s degree from an accredited college or university
  • Minimum of 5 years of field customer experience and/or account management
  • Minimum of 3 years Healthcare Professional experience with relevant CNS/Psychiatry experience
  • Previous pharmaceutical, biotech, or medical marketing/sales experience with at least five years in specialty sales
  • CNS/Psychiatry experience strongly preferred
  • Launch experience strongly preferred
  • Must live in the territory's geography
  • Experience strategizing within cross-functional teams
  • Proven ability to successfully manage multiple tasks concurrently under aggressive timelines
  • Comfortability with uncertainty and high expectations
  • Patient support services experience a plus
  • Strong digital marketing aptitude
  • Strong interpersonal, presentation, and communication skills
Responsibilities
  • Proficient in both virtual and live customer engagements
  • Develop a comprehensive and effective territory business plan
  • Promote Auvelity within approved labeling in a comprehensive, fair, and ethical manner
  • Develop strong customer relationships
  • Serve as a resource/consultant to customers and staff regarding payer policies and processes
  • Maximize use of marketing resources to maintain and develop customer relationships
  • Communicate territory activity in an accurate and timely manner
  • Provide feedback to sales and commercial leadership
  • Successfully complete all training classes
  • Complete administrative duties in an accurate and timely fashion
  • Manage efforts within assigned promotional budget
  • Effectively collaborate across all corporate functions
  • Attend medical congresses and society meetings
  • Ensure timely access for patients through patient services and savings programs
  • Minimal overnight travel as indicated by the needs of the business
  • Additional responsibilities as assigned
Axsome Therapeutics Inc

Axsome Therapeutics Inc

View

Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain to help regulate mood. This drug has shown positive results in clinical trials and has received FDA Breakthrough Therapy Designation, which speeds up its development process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and clinical trials. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.

Company Stage

IPO

Total Funding

$430.7M

Headquarters

New York City, New York

Founded

2012

Growth & Insights
Headcount

6 month growth

92%

1 year growth

92%

2 year growth

92%
Simplify Jobs

Simplify's Take

What believers are saying

  • The launch of Auvelity and the promising results of AXS-12 in Phase 3 trials indicate strong potential for revenue growth and market impact.
  • Axsome's strategic expansion of its sales force to support Auvelity's launch demonstrates its commitment to commercial success.
  • The appointment of experienced leaders like Dr. Sue Mahony to the board enhances Axsome's strategic direction and governance.

What critics are saying

  • The biopharmaceutical sector's inherent risks, including regulatory hurdles and clinical trial failures, could impact Axsome's progress.
  • High competition in the CNS disorder treatment market may challenge Axsome's ability to capture significant market share.

What makes Axsome Therapeutics Inc unique

  • Axsome Therapeutics focuses on CNS disorders with a strong emphasis on unmet medical needs, setting it apart from broader biopharmaceutical companies.
  • The FDA Breakthrough Therapy Designation for AXS-05 highlights its innovative approach and potential for rapid market entry.
  • Axsome's diversified pipeline, including treatments for MDD, TRD, Alzheimer's agitation, and narcolepsy, showcases its comprehensive strategy in CNS therapeutics.
INACTIVE